Coherus BioSciences is a biotechnology company that develops and commercializes biosimilar therapeutics, primarily focusing on oncology and other high-need therapeutic areas. The company is committed to improving patient access to high-quality, affordable medications through its robust portfolio, which includes both marketed and investigational products. Coherus places a strong emphasis on innovation, collaboration, and integrity in its operations, striving to advance healthcare by leveraging scientific expertise and forming partnerships within the medical community. With a workforce dedicated to patient-centricity, Coherus aims to bridge the gap in treatment options for patients, particularly in oncology, while upholding a culture of compliance and ethical standards in all business practices.